NS · Healthcare

Walpar Nutritions Ltd (WALPAR)

Pharmaceuticals & Biotechnology

Walpar Nutritions Ltd (WALPAR) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-03, reported market cap is $228.70M, P/E ratio is 13.64. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for WALPAR

Market cap

$228.70M

P/E ratio

13.64

Walpar Nutritions Ltd (WALPAR) — FAQ

What is Walpar Nutritions Ltd's market cap?

Walpar Nutritions Ltd (WALPAR) has a reported market cap of $228.70M (data as of 2026-07-03).

What is WALPAR's P/E ratio?

The price-to-earnings (P/E) ratio for Walpar Nutritions Ltd (WALPAR) is 13.64 (data as of 2026-07-03).

Does Walpar Nutritions Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Walpar Nutritions Ltd (WALPAR). Check the MyAverix Finance app for the latest dividend data.

What sector is Walpar Nutritions Ltd in?

Walpar Nutritions Ltd (WALPAR) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is WALPAR listed on?

WALPAR is listed on NS.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)